TY - JOUR
T1 - The changing faces of IgG4-related disease
T2 - Clinical manifestations and pathogenesis
AU - Islam, Arshia Duza
AU - Selmi, Carlo
AU - Datta-Mitra, Ananya
AU - Sonu, Rebecca
AU - Chen, Mingyi
AU - Gershwin, M. Eric
AU - Raychaudhuri, Siba P.
N1 - Publisher Copyright:
© 2015.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Since the earliest reports in 2001, immunoglobulin G4 (IgG4)-related disease has been defined as an autoimmune systemic disease characterized by the lymphoplasmacytic infiltration of affected tissues leading to fibrosis and obliterative phlebitis along with elevated serum IgG4 levels. Prior to this unifying hypothesis, a plethora of clinical manifestations were considered as separate entities despite the similar laboratory profile. The pathology can be observed in virtually all organs and may thus be a challenging diagnosis, especially when the adequate clinical suspicion is not present or when obtaining a tissue biopsy is not feasible. Nonetheless, the most frequently involved organs are the pancreas and exocrine glands but these may be spared. Immunosuppressants lead to a prompt clinical response in virtually all cases and prevent histological sequelae and, as a consequence, an early differential diagnosis from other conditions, particularly infections and cancer, as well as an early treatment should be pursued. We describe herein two cases in which atypical disease manifestations were observed, i.e., one with recurrent neck lymph node enlargement and proptosis, and one with jaundice. Our understanding of the pathogenesis of IgG4-related disease is largely incomplete but data support a significant role for Th2 cytokines with the contribution of innate immunity factors such as Toll-like receptors, macrophages and basophils. Further, macrophages activated by IL4 overexpress B cell activating factors and contribute to chronic inflammation and the development of fibrosis. We cannot rule out the possibility that the largely variable disease phenotypes reflect different pathogenetic mechanisms and the tissue microenvironment may then contribute to the organ involvement.
AB - Since the earliest reports in 2001, immunoglobulin G4 (IgG4)-related disease has been defined as an autoimmune systemic disease characterized by the lymphoplasmacytic infiltration of affected tissues leading to fibrosis and obliterative phlebitis along with elevated serum IgG4 levels. Prior to this unifying hypothesis, a plethora of clinical manifestations were considered as separate entities despite the similar laboratory profile. The pathology can be observed in virtually all organs and may thus be a challenging diagnosis, especially when the adequate clinical suspicion is not present or when obtaining a tissue biopsy is not feasible. Nonetheless, the most frequently involved organs are the pancreas and exocrine glands but these may be spared. Immunosuppressants lead to a prompt clinical response in virtually all cases and prevent histological sequelae and, as a consequence, an early differential diagnosis from other conditions, particularly infections and cancer, as well as an early treatment should be pursued. We describe herein two cases in which atypical disease manifestations were observed, i.e., one with recurrent neck lymph node enlargement and proptosis, and one with jaundice. Our understanding of the pathogenesis of IgG4-related disease is largely incomplete but data support a significant role for Th2 cytokines with the contribution of innate immunity factors such as Toll-like receptors, macrophages and basophils. Further, macrophages activated by IL4 overexpress B cell activating factors and contribute to chronic inflammation and the development of fibrosis. We cannot rule out the possibility that the largely variable disease phenotypes reflect different pathogenetic mechanisms and the tissue microenvironment may then contribute to the organ involvement.
KW - Autoimmune disease
KW - Diagnostic criteria
KW - Histology
KW - Lymphoproliferative
KW - Pancreatitis
KW - Plasma cells
KW - Sclerosing fibrosis
UR - http://www.scopus.com/inward/record.url?scp=84940614717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940614717&partnerID=8YFLogxK
U2 - 10.1016/j.autrev.2015.06.003
DO - 10.1016/j.autrev.2015.06.003
M3 - Review article
C2 - 26112170
AN - SCOPUS:84940614717
SN - 1568-9972
VL - 14
SP - 914
EP - 922
JO - Autoimmunity Reviews
JF - Autoimmunity Reviews
IS - 10
ER -